Position in ARGX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$346,985
+$76,793 QoQ
Shares Held
374
+1.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#338
of 504 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026West Family Investments, Inc. holds $2,539,425 across 7 Biotechnology names. ARGX ranks #3 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,695 | $841,957 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,017 | $634,140 | |
| 3 | ARGX |
Argenx SE
This page
|
374 | $346,985 | |
| 4 | INCY |
Incyte Corp
|
2,161 | $244,970 | |
| 5 | RPRX |
Royalty Pharma plc
|
4,288 | $240,428 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
767 | $230,890 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
35,500 | $55 |
All Filings in ARGX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $346,985 | 374 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $270,192 | 370 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $489,432 | 582 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $404,920 | 549 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $286,634 | 520 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $250,920 | 408 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||